Etrasimod
- Generic Name
- Etrasimod
- Brand Names
- Velsipity
- Drug Type
- Small Molecule
- Chemical Formula
- C26H26F3NO3
- CAS Number
- 1206123-37-6
- Unique Ingredient Identifier
- 6WH8495MMH
- Background
Etrasimod is a synthetic next-generation selective Sphingosine 1-phosphate (S1P) receptor modulator that targets the S1P with no detectable activity on S1P and S1P receptors. S1P receptors are membrane-derived lysophospholipid signaling molecules that are involved in the sequestration of circulating peripheral lymphocytes in lymph nodes. Therefore, S1P recep...
- Indication
Etrasimod is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
- Associated Conditions
- Moderately to Severely Active Ulcerative Colitis
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath